argenx SE Sustainability Reports
argenx SE is a global clinical-stage biopharmaceutical company specializing in immunology. It focuses on developing antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
Sector: Manufacturing
Country: Netherlands
Exchange: Euronext Brussels
ISIN: NL0010832176
16 reports from 2014 to 2025